RxBNTysabri
natalizumab
1 reference · 1 biosimilar-only
Reference Product
Tysabri
natalizumab
351(a) Reference Product (Approval Date 23-Nov-2004)
ApplicantBiogen Inc.
BLA125104
RouteIntravenous
Presentation
Single-Dose Vial
Tysabri
natalizumab
351(a) Reference Product (Approval Date 23-Nov-2004)
ApplicantBiogen Inc.
BLA125104
·RouteIntravenous
Presentation
Single-Dose Vial
Interchangeable Biosimilars
No interchangeable biosimilars in this group.
Biosimilars (not interchangeable)
Tyruko
natalizumab-sztn
351(k) Biosimilar (Approval Date 24-Aug-2023)
ApplicantSandoz Inc.
BLA761322
RouteIntravenous
Presentation
Single-Dose Vial
Tyruko
natalizumab-sztn
351(k) Biosimilar (Approval Date 24-Aug-2023)
ApplicantSandoz Inc.
BLA761322
·RouteIntravenous
Presentation
Single-Dose Vial